Ask AI
Bill116th CongressFiled Oct 23, 2019Crime and Law Enforcement
H.R. 4812

Ensuring Compliance Against Drug Diversion Act of 2020

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house (Nov 17, 2020)

Ensuring Compliance Against Drug Diversion Act of 2020

This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances.

It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.

What just happenedNov 18, 2020

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Who’s behind it

Rep. Griffith, H. Morgan [R-VA-9](R-VA)Sponsor
1 cosponsor1 R
Read on Congress.gov
1cosponsors3committees20actions3subjects
  1. Nov 18, 2020IntroReferral

    Received in the Senate and Read twice and referred to the Committee on the Judiciary.

    Judiciary Committee
  2. Nov 17, 2020FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. Nov 17, 2020FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5819)

  4. Nov 17, 2020Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5819)

  5. Nov 17, 2020FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 4812.

  6. Nov 17, 2020FloorH30000

    Considered under suspension of the rules. (consideration: CR H5819-5820)

  7. Nov 17, 2020FloorH30300

    Mr. Pallone moved to suspend the rules and pass the bill, as amended.

  8. Nov 16, 2020CalendarsH12410

    Placed on the Union Calendar, Calendar No. 482.

  9. Nov 16, 2020DischargeH12300

    Committee on the Judiciary discharged.

    Judiciary Committee
  10. Nov 16, 2020Committee5500

    Committee on the Judiciary discharged.

    Judiciary Committee
  11. Nov 16, 2020CommitteeH12200

    Reported by the Committee on Energy and Commerce. H. Rept. 116-584, Part I.

    Energy and Commerce Committee
  12. Nov 16, 2020Committee5000

    Reported by the Committee on Energy and Commerce. H. Rept. 116-584, Part I.

    Energy and Commerce Committee
  13. Sep 9, 2020Committee

    Ordered to be Reported by Voice Vote.

    Energy and Commerce Committee
  14. Sep 9, 2020Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  15. Nov 15, 2019Committee

    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

    Crime and Federal Government Surveillance Subcommittee
  16. Oct 26, 2019Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  17. Oct 23, 2019IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Judiciary Committee
  18. Oct 23, 2019IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  19. Oct 23, 2019IntroReferralIntro-H

    Introduced in House

  20. Oct 23, 2019IntroReferral1000

    Introduced in House

Passed HouseNov 17, 202053

Ensuring Compliance Against Drug Diversion Act of 2020

This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances.

It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.

Reported to House, Part INov 16, 20208

Ensuring Compliance Against Drug Diversion Act of 2019

This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances.

It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.

Introduced in HouseOct 23, 2019

Ensuring Compliance Against Drug Diversion Act of 2019

This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances.

It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.

Ensuring Compliance Against Drug Diversion Act of 2020 — Informed